Question 1

What specific information will the biopsy provide about my psoriasis?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Molecular Markers in Cutaneous Inflammation Between Psoriatic Lesional Skin and Healthy Non-lesional Skin clinical trial (NCT03423004). Contact the study team or your healthcare provider for specific answers.

Question 2

How will this study help improve treatment options for psoriasis?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Molecular Markers in Cutaneous Inflammation Between Psoriatic Lesional Skin and Healthy Non-lesional Skin clinical trial (NCT03423004). Contact the study team or your healthcare provider for specific answers.

Question 3

Are there any risks associated with the biopsy procedure?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Molecular Markers in Cutaneous Inflammation Between Psoriatic Lesional Skin and Healthy Non-lesional Skin clinical trial (NCT03423004). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens to my skin samples after the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Molecular Markers in Cutaneous Inflammation Between Psoriatic Lesional Skin and Healthy Non-lesional Skin clinical trial (NCT03423004). Contact the study team or your healthcare provider for specific answers.

Question 5

Will I receive any results from the biopsy, and how will they be used?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Molecular Markers in Cutaneous Inflammation Between Psoriatic Lesional Skin and Healthy Non-lesional Skin clinical trial (NCT03423004). Contact the study team or your healthcare provider for specific answers.

What this study is about